|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, TCL1, 14q32.1, TC
Test CodeCPT Codes
88271 x 2, 88275<br>Restricted Client Code - Tech Only
Preferred Specimen
Minimum Volume
Other Acceptable Specimens
Instructions
Clinical history/reason for referral is required with test order. Prior therapy and transplant history should be provided with test order.
1-3 mL bone marrow in transport medium or 3-5 mL whole blood in a sodium heparin (green-top, dark/royal blue-top, tan-top) tube. Formalin fixed paraffin embedded tumor biopsy.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not freeze. Do not reject.
Transport Temperature
Specimen Stability
Methodology
Fluorescence in situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Clinical Significance
The proto-oncogene TCL1, located at 14q32.1, is overexpressed in a variety of lymphoid neoplasms, including T-cell prolymphocytic leukemia (T-PLL), T-cell acute lymphoblastic leukemia/lymphoma (T-ALL/LBL), Epstein-Barr virus (EBV)-infected B-cell lymphomas, and AIDS-related lymphomas. The overexpression of TCL1 usually results from juxtaposition to a T-cell receptor locus via a translocation or inversion.
100-300 interphase cells are microscopically analyzed for probe signal patterns indicating rearrangement of 14q32.1.